Financial reports

ANNUAL REPORT 2017

16 May, 2018

Läs mer

KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER

26 April, 2018

INTERIM REPORT JANUARY – MARCH 2018 · Net sales amounted to MSEK 267.1 (139.3), equivalent to an increase of 91.7%. Growth was mainly due to acquisitions. · Organic growth was +10.7%, whereof pharmaceuticals +18.8% and other products +4% · The gross margin was 56.8% (53.7%) for the period. · EBITDA amounted to MSEK 88.7 (43.7),...

Läs mer

YEAR-END REPORT 2017

22 February, 2018

THE FULL YEAR AND FOURTH QUARTER · Net sales amounted to MSEK 657.6 (347.3), whereof the fourth quarter MSEK 238.7 (96.5), representing an increase of 89 percent for the year and 147 percent for the quarter. · Adjusted EBITDA amounted to MSEK 169.3 (51.7), whereof the fourth quarter MSEK 41.8 (28.9) representing a margin of...

Läs mer